Lazard Ltd. (LAZ) Tops Q4 EPS by 12c

Lazard Ltd. (NYSE: LAZ) reported Q4 EPS of $1.13, $0.12 better than the analyst estimate of $1.01. Revenue for the quarter came in at $685 million versus the consensus estimate of $679.7 million.

For earnings history and earnings-related data on Lazard Ltd. (LAZ) click here.

You May Also Be Interested In

• Procter & Gamble falls on weak sales, cautious guidance
• Teva Pharma (TEVA) Misses Q2 EPS by 60c ; Offers Guidance
• Verisk Analytics (VRSK) Tops Q2 EPS by 5c ; Offers Guidance